Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study

OBJECTIVES: To prospectively validate that the inability to decrease procalcitonin levels by more than 80% between baseline and day 4 is associated with increased 28-day all-cause mortality in a large sepsis patient population recruited across the United States. DESIGN: Blinded, prospective multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuetz, Philipp, Birkhahn, Robert, Sherwin, Robert, Jones, Alan E., Singer, Adam, Kline, Jeffrey A., Runyon, Michael S., Self, Wesley H., Courtney, D. Mark, Nowak, Richard M., Gaieski, David F., Ebmeyer, Stefan, Johannes, Sascha, Wiemer, Jan C., Schwabe, Andrej, Shapiro, Nathan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389588/
https://www.ncbi.nlm.nih.gov/pubmed/28257335
http://dx.doi.org/10.1097/CCM.0000000000002321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389588/
https://www.ncbi.nlm.nih.gov/pubmed/28257335
http://dx.doi.org/10.1097/CCM.0000000000002321

Ejemplares similares